Showing 2131-2140 of 2976 results for "".
- DocClocker App Now Features Remote Check-In to Prevent Spread of COVID-19 in Medical Practiceshttps://modernaesthetics.com/news/docclocker-app-now-features-remote-check-in-to-prevent-spread-of-covid-19-in-medical-practices/2472956/DocClocker, an app that allows patients to receive real-time wait time reporting of their medical providers, enabling patients to avoid long waits in medical waiting rooms and limit COVID-19 exposure risks, now offers DocClocker Remote Check-In. As practices reopen amid the COVID-19 pan
- Candela’s CO2RE Laser Platform Scores Health Canada Approval for Two New Gynecological Indicationshttps://modernaesthetics.com/news/candelas-co2re-laser-platform-scores-health-canada-approval-for-two-new-gynecological-indications/2472955/Health Canada has approved Candela’s CO2RE laser for the treatment of genitourinary syndrome of menopause (GSM) and stress urinary incontinence (SUI) in adult women. The CO2RE laser, a sing
- Bimini Health Tech Acquires Healeonhttps://modernaesthetics.com/news/bimini-health-tech-acquires-healeon/2472954/Bimini Health Tech has acquired Healeon Medical, Inc., a company that designs, develops, manufactures, and markets medical devices for autologous, point-of-care treatments. Healeon's products include: the signature
- FDA Approves Juvéderm Voluma XC for Augmentation for Chin Regionhttps://modernaesthetics.com/news/fda-approves-juvederm-voluma-xc-for-augmentation-for-chin-region/2472953/The FDA has approved Allergan Aesthetics' Juvéderm Voluma XC for the augmentation of the chin region to improve the chin profile in adults over the age of 21. According to Allergan Aesthetics, an AbbVie company, the Juvéderm Collection of Fillers has the broadest portfolio of sp
- Alastin Skincare's INhance Post-Injection Serum Speeds Recoveryhttps://modernaesthetics.com/news/alastin-skincares-inhance-post-injection-serum-speeds-recovery/2472951/Alastin’s Skincare’s INhance Post-Injection Serum with TriHex Technology can help reduce post-injection bruising and swelling, according to a report inthe Journal of Drugs in
- ASPS: Many Americans Look Forward to Plastic Surgery in Post COVID-19 Worldhttps://modernaesthetics.com/news/asps-many-americans-look-forward-to-plastic-surgery-in-post-covid-19-world/2472948/Americans report a positive attitude about plastic surgery even during the COVID-19 pandemic, according to a new survey from the American Society of Plastic Surgery. In the survey of more than 1,000 consumers who were polled during the pandemic, 49 percent of those who haven't had p
- RealSelf Medical Advisory Board Adds Plastic Surgeon Dr. Arian Mowlavihttps://modernaesthetics.com/news/realself-medical-advisory-board-adds-newport-beach-plastic-surgeon-dr-arian-mowlavi/2472947/Newport Beach, Calif.-based plastic surgeon Arian Mowlavi, MD is now a member of RealSelf’s Medical Advisory Board. “RealSelf is a leader in plastic surgery patient education and I am proud to a member of their Medical Advisory Board,” says Dr. Mowlavi of Cosmetic Plas
- Meet Cynosure’s Upgraded Elite iQ Aesthetic Workstationhttps://modernaesthetics.com/news/meet-cynosures-upgraded-elite-iq-aesthetic-workstation/2472944/Cynosure is launching the Elite iQ platform – the next generation of Cynosure’s Elite+ Aesthetic Workstation and the first Alexandrite-ND: YAG System to U.S., European and Australian mark
- New Officers Announced at American Society for Laser Medicine and Surgeryhttps://modernaesthetics.com/news/new-officers-announced-at-american-society-for-laser-medicine-and-surgery/2472943/Thomas E. Rohrer, MD was introduced as President of the American Society for Laser Medicine and Surgery (ASLMS) during the Board of Directors meeting on April 30, 2020. ASLMS is the world's largest professional organization dedicated to promoting research, education, and high standards of cli
- Revance to Acquire HintMDhttps://modernaesthetics.com/news/revance-to-aquire-hintmd/2472941/Revance Therapeutics, Inc. has acquired HintMD, a financial technology platform for the aesthetics industry. Revance has agreed to pay HintMD’s shareholders a total of 8.54 million shares of Revance common stock, subject to customary adjustments provided in the acquisition agreeme